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Abstract
Introduction and objective. The incidence of sarcoidosis (D.86.0, D.86.2) varies worldwide, although published data 
suggest that the rate remains at the level 10–40/100 000 population. In Poland, statistics are not conducted on sarcoidosis. 
The etiology of the disease remains unclear, but researchers suggest that one of causes is the exposure to environmental 
factors. The aim of this study is to determine territorial and temporal variations of incidence and hospitalized prevalence 
of sarcoidosis for adults aged 19 and older living in the Silesian voivodeship in south-western Poland.   
Materials and methods. To identify the number of cases of sarcoidosis and the number of hospitalized patients in 2006–
2010, the database of the National Health Fund in Katowice, Silesia, was used. Data related to adults aged 19 and older 
who were inhabitants of the Silesian voivodeship. Standardized incidence and prevalence rates for total sarcoidosis per 
100,000 population were calculated using the world standard population. Temporal and spatial variability of both rates in 
the Silesian voivodeship were presented according to ArcGIS 9.2.   
Results. The number of new cases of sarcoidosis is still increasing. The disease occurred primarily in younger men (25–50 
years of age), as well as in some older women (age group 50–64 years). Standardized incidence rates of total sarcoidosis 
are in the range 3.8–4.5/100,000 population. There was a probable relationship between the incidence of sarcoidosis and 
the area of forest (r=0.4) or arable land (r=0.3).   
Conclusions. Sarcoidosis is a rare disease in the Silesian voivodeship and the standardized incidence and prevalence rates 
are slightly higher in men than in women. In the study period, spatial variability was observed. The highest rates were typical 
for districts with a predominance of forests and arable land.
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INTRODUCTION
Sarcoidosis (D.86.0 and D.86.2 according to ICD-10) is an 
interstitial lung disease of unknown cause [1]. The incidence 
varies worldwide although published data suggest that the 
rate remains at the level 10 – 40/100,000 population [2]. 
Higher rates of incidence are noted in the population of 
Northern Europe, with a value 64/100,000 in Sweden and 
43/100,000 in Germany. Smaller values are characteristic 
for the southern European countries, e.g., 9/100, 000 in Italy 
[3]. Current Polish data suggest that the incidence rate is 
in the rather low ranges (10/100,000) [3] and evaluated for 
people over 14 years old. In the Radom region of Poland, it 
was even smaller, at the level 2.3/100,000 population [2]. It 
is believed that this number may be underestimated because 
of the natural history of the disease and diagnostic problems 
[4]. Hospital mortality in patients with sarcoidosis is low and 
stands at 0.56%. It is worth noting that it is much smaller 
than in patients hospitalized for other interstitial lung 
diseases [2]. The disease usually affects young people, with 
a peak incidence between 20 – 29 years of age, and usually 
women over 50 years of age. The course of the disease varies 
in different populations, from a chronic lung disease to 
disorders of calcium metabolism [3]. As already mentioned, 
the etiology of the disease remains unclear. The most 
likely cause of sarcoidosis is considered to be genetically-
determined deficiency of cellular immunity [5, 6, 7, 8, 9, 10]. 
The results of the American ACCESS (A Case Control Study 
of Sarcoidosis Etiology) suggest a causal relationship between 
the disease and occupational exposure to insecticides and 
pollution mycobacteria [11]. These premises have become 
an argument for an epidemiological study plan aimed at 
fixing the recorded incidence and prevalence of hospitalized 
due to sarcoidosis in the Silesian region, and to assess their 
variability over time.
OBJECTIVE
The aim of this study was to determine the territorial and 
temporal variation of incidence and hospitalized prevalence 
of sarcoidosis in adults aged 19 and older living in the Silesian 
voivodeship.
MATERIAL AND METHODS
To identify the number of cases of sarcoidosis, and the number 
of patients treated in hospitals in the years 2006–2010, the 
database of the National Health Fund in Katowice, Silesia, 
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were used. It included the following information: metrical 
data, such as date of birth and gender of the patient, patient’s 
administrative affiliation with regard to place of residence 
(to the nearest county), as well as data on the treatment, 
i.e., the main diagnosis, date of first illness, date of first 
hospitalization, number of further medical advice, number 
of subsequent hospitalizations, year of death. The analyses 
included only data of patients permanently domiciled in the 
Silesian voivodeship. Data related to adults aged 19 and older, 
were presented in a way that provide anonymity of patients. 
Sarcoidosis of lungs (D.86.0), and sarcoidosis of lungs with 
sarcoidosis of lymph nodes (D.86.2), were considered; both 
codes have been adopted by the International Classification 
of Diseases and Related Health Problems (ICD-10) [12]. 
For the presented study, the mean age of the patients was 
calculated, and the percentage of people hospitalized due 
to total sarcoidosis in 4 age groups: 19–34, 35–54, 55–64, 
and 65 or more years. The percentage changes during the 
study period was then examined, separately for men and 
women. Finally, crude prevalence and incidence rates for total 
sarcoidosis per 100,000 population were calculated. Crude 
rates were the direct standardized procedure using the WHO 
world standard population [13]. This assessment takes into 
account local differences and the territorial administrative 
division (NTS-4), including all counties and cities and 
towns in the province of Silesia. According to the definition, 
NUTS (Nomenclature of Territorial Units for Statistics) is 
an ordered list of names of political subdivisions and their 
associated symbols used in the collection of statistics by 
the Central Statistical Office (GUS) [14]. Maps were drawn 
showing variations for the period 2006–2010, averaged 
standardized values of incidence rates and hospitalization 
of total sarcoidosis in Silesian counties, using geographic 
information system ArcGIS 9.2 software.
RESULTS
The results of basic analysis are summarized in Table 1. Data 
show that the number of new cases of sarcoidosis among 
adults aged 19 years and older in the Silesian voivodeship 
during the study period (years 2006–2010) is systematically 
growing. In addition, the increase of outpatient care 
participation in the diagnosis of sarcoidosis, which had been 
reported previously in the hospital, was observed. The highest 
number of deaths among people with diagnosed sarcoidosis 
(D.86.0 and D.86.2) was recorded in 2007. It is worth noting 
that in the Silesian voivodeship the most common form of 
the disease is sarcoidosis of lungs (n = 966 out of all 1217 
diagnoses in 2006–2010), which represents 79.4% of total 
cases (Fig. 1).
The average age of adult patients at onset in subsequent 
reporting years was 42.4 – 46.2 years. It is worth noting that 
the largest group of patients were those aged 35–54 years, 
and least numerous were older people, over 65 years of age 
(Tab. 2).
Figure 2 shows the changes in the age structure of people 
diagnosed with total sarcoidosis by gender in the following 
years. It should be noted that throughout the study period 
(2006 – 2010) medical doctors frequently recorded disease 
in younger men (between 25 – 50 years of age), as well as in 
some older women (age group 50–64 years).
According to the methodology, appropriate crude 
prevalence and incidence rates of total sarcoidosis for the 
Silesian voivodeship have been calculated, and next, both 
coefficients were standardized. (Tab. 3). Depending on the 
year, crude incidence rates of total sarcoidosis were in the 
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Table 1. Number of new cases, medical visits and number of hospitalization 
due to total sarcoidosis (D.86) in adults aged 19 years and older living 
in Silesian voivodeship
Year
Total
cases
N (100%)
No. of
first-time
medical
visits
N (%)
No. of
first-time
hospitali-
zation
N (%)
No. of
medical
outpatient
visits
N
No. of
hospitali-
zation
N
No. of
deaths
N (%)
2006 192   1 (1%) 191 (99%)  7 323   8 (4.2%)
2007 229   3 (1%) 226 (99%)  5 371 21 (9.2%)
2008 253 10 (4%) 243 (96%) 50 422   6 (2.4%)
2009 276 36 (13%) 240 (87%) 75 404   6 (2.2%)
2010 267 53 (20%) 214 (80%) 75 267   7 (2.6%)
Figure 1. Number of registered incidence of lung sarcoidosis (D86.0) and sarcoidosis 
of lungs with sarcoidosis of lymph nodes (D86.2) in years in the Silesian voivodeship
Table 2. Number of total cases of sarcoidosis (D.86) in adults aged 19 
and older living in Silesian voivodeship by age
Year
No. and percentage of cases
Average
of the age
X ± SD
Total
population
N
19–34 
years
N (%)
35–54 
years
N (%)
55–64 
years
N (%)
65 + years
N (%)
2006 192 54 (28%)   95 (49%) 32 (17%) 11 (6%) 43.7±13.0
2007 229 61 (27%) 115 (50%) 35 (15%) 18 (8%) 44.6±12.6
2008 253 83 (33%) 118 (47%) 43 (17%)   9 (4%) 42.4±12.2
2009 276 54 (20%) 150 (54%) 48 (17%) 24 (9%) 46.2±12.6
2010 267 80 (30%) 110 (41%) 62 (23%) 15 (6%) 44.9±13.0
Table 3. Crude and standardized incidence and prevalence of total 
sarcoidosis (n/100 000) in general, male and female population aged 19 
years and more, Silesian voivodeship
Year
Incidence (n/100 000 population)
in adults aged 19 years and older
Prevalence (n/100 000 population)
in adults aged 19 years and older
Crude 
rates
Standardized rates Crude 
rates
Standardized rates
All Women Men All Women Men
2006 5.1 3.8 3.3 4.3 5.1 3.3 3.2 3.2
2007 6.1 3.8 3.3 4.3 6.0 3.7 3.2 4.3
2008 6.7 4.3 3.4 5.2 6.5 4.1 3.2 5.0
2009 7.3 4.5 4.4 4.5 6.4 3.9 3.6 4.2
2010 7.1 4.3 3.5 5.0 5.7 3.4 2.8 4.1
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range 5.1 – 7.3/100,000 population aged 19 and older, while 
the standardized rates were slightly smaller and amounted 
to 3.8 – 4.5/100,000.
Figure 3 shows the averaged values of standardized 
incidence rate of total sarcoidosis (the value was averaged 
for the period 2006–2010 in particular districts of the Silesian 
region), while Figure 4 reflects the diversity of territorial 
averaged values of hospitalized prevalence rate. In both cases, 
the highest values refers to Żywiec district and the cities of 
Częstochowa and Bielsko Biała.
DISCUSSION
According to the aim of the presented study, registry data 
on the incidence and hospitalized prevalence of sarcoidosis 
(D.86) in the Silesian voivodeship was analyzed. Among 
adults (persons aged 19 and over) who were residents of 
the region, from 192 – 276 cases of the disease per year 
were diagnosed. The predominant form of the disease is 
sarcoidosis of lungs (D.86.0 according to ICD-10), which 
accounts for over three-quarters of all diagnosed cases in 
the period 2006–2010. The standardized incidence rate of 
sarcoidosis was variable during the period and stood at 
3.8 – 4.5/100,000 for the total population. It is worth noting 
that it was slightly lower in women (3.3 – 4.4/100,000) than 
men (4.3 – 5.2/100, 000). These results suggest that Poland 
is a country with a rather low-incidence of sarcoidosis [2, 3].
Analysis of the data found that during the study period 
the disease was frequently recorded in younger men (25 – 34 
Figure 2. Percentage of new cases of total sarcoidosis (D.86) in adults aged 19 and 
older living in the Silesian voivodeship by gender and age in 2006–2010
Figure 3. Mean value of the standardized incidence of total sarcoidosis in 
population of 19+ years (n/100 000), Silesian voivodeship, value averaged for the 
period 2006–2010
Figure 4. Mean value of standardized coefficient describes the number of first-time 
hospitalization for total sarcoidosis in a population of 19+ years (n/100 000) in the 
Silesian voivodeship. Value averaged for the period 2006–2010
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years of age) and older women (50 years old). The age profile 
is consistent with previous observations by other authors 
[1, 3]. The percentage of patients with sarcoidosis who died 
were at the level 2.2 -2.6% in the last years of observation 
(2008–2010). Unfortunately, the lack of information on the 
cause of death in the obtained database does not allow for the 
calculation of mortality. Available data indicate that specific 
mortality due to sarcoidosis is relatively low in Poland and 
does not exceed 0.6% [2].
There was considerable variation of averaged rate of 
incidences and hospitalization in the particular voivodships 
for the study period (years 2006–2010). The highest values 
of standardized incidence were recorded in Żywiec, Gliwice 
and Częstochowa counties. The highest prevalence occurred 
in Żywiec and Częstochowa counties. There is insufficient 
knowledge about the risk factors of sarcoidosis; therefore, this 
fact significantly impedes the explanation of the variation. 
Reports by other authors point to the potential role of 
exposure to environmental factors, such as occupational 
exposure to insecticides and mycobacteria [11]. From this 
perspective, it is worth noting that the largest incidence 
and hospitalization due to sarcoidosis occurred in districts 
with a majority of arable land and/or forest, where perhaps 
the use of plant protection products can also be larger [14]. 
Additional analyses showed a positive ecological correlation 
between the incidence of sarcoidosis and the area of forest (r 
= 0.4) or arable land (r = 0.3), in the absence of circumstances 
such as the importance – in districts – of the unemployment 
rate, average monthly salary, availability of medical doctors 
and hospital beds. The visualized ecological effect deserves 
verification during the study in order to follow the cause-
effect relationships.
Among the other important reasons for epidemiological 
differentiation of sarcoidosis in the Silesian voivodeship is 
different access to diagnostic procedures. Against this type 
of interpretation, there are greater intensity ratios in districts 
with lower levels of urbanization. Distortion is also possible 
due to differences in the recording of cases of sarcoidosis. 
This issue can affect the observed territorial and temporal 
variation, but its outcome is not possible on the basis of 
available data.
It should also be noted that the hospitalized prevalence 
rates in the first years of observation (2006–2008) were 
similar to those of incidence. The last two years showed a 
marked reduction in the hospitalization rates of sarcoidosis, 
which may confirm the growing importance of outpatient 
care in the treatment of patients.
CONCLUSIONS
In summarizing the obtained results, it is clear that 
sarcoidosis is a rare disease in the Silesian voivodeship, 
where the incidence is similar to that estimated for the Polish 
population. The standardized incidence and prevalence rates 
are slightly higher in men than women, and the proper 
variability in 2006–2010 was small. However, significant 
territorial differentiation was observed, with the highest 
value of both indicators in the districts of Żywiec, Gliwice, 
Częstochowa and Bielsko Biała.
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